Skip to main content
. 2016 Nov 5;7(49):80957–80966. doi: 10.18632/oncotarget.13133

Figure 5. The miRNA+piRNA signature predicts overall survival in lung squamous cell carcinoma patients.

Figure 5

Risk scores calculated based on (A) miRNA signatures and (B) miRNA+piRNA signatures. Patients were assigned to high (red), intermediate (green), and low (blue) risk groups and Kaplan-Meier survival curves were compared. (C) Risk group classifications were compared based on the miRNA-only (top) and miRNA+piRNA (bottom) signatures. Risk group colors are the same as in the above panels.